Saturday, July 5, 2025

Latest

AMD: First Quarter Analyst Consensus Estimates

Advanced Micro Devices (NASDAQ: AMD) will be reporting their first quarter financial results on April 27th after market close. Analysts have a consensus $102.50 12-month price target on the company, via a total of 39 analysts, with six analysts having strong buy ratings. 18 analysts meanwhile have buy ratings, 13 have hold ratings, 1 analyst has a sell rating and 1 has a strong sell rating on the company. The street high comes from Elazar Advisors with a $161.90 price target, and the lowest target sits at $59 from Clevelland Research.

29 analysts have revenue estimates for the first quarter. The mean revenue estimate between all 29 analysts is $3.22 billion; this number has been revised upwards from $2.73 billion at the start of the year. The highest revenue estimate is $3.3 billion, while the lowest is $3.1 billion.

Onto EBITDA estimates, there are currently only 8 analysts who have first-quarter EBITDA estimates. The mean is currently $718.9 million, with this number having been revised upwards from $519.11 million at the start of the year. The street high estimate currently sits at $739.2 million in EBITDA and the lowest is $651.5 million.

Analysts estimate that quarterly earnings per share will come in at $0.45, with this number being slightly revised upwards from $0.35 at the start of the year. Street high is $0.48 and the lowest estimate is $0.35 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Dundee Acquires Adriatic Metals: The Balkan Growth Strategy

Gold Drilling Scaled to 60,000 Meters: How Big Can This Get? | Roger Rosmus – Goliath Resources

Baselode Energy To Acquire Forum Energy: The Merger Of Equals Deal

Recommended

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Related News

Psyched Wellness: Canaccord Pens “Future In Fungi Report”

Yesterday morning, Canaccord Genuity released a primer into five psychedelic companies that they “believe could...

Tuesday, March 9, 2021, 11:49:00 AM

Medipharm Labs Receives Price Target Reduction From Canaccord To $1.75

Yesterday, On November 16th, Medipharm Labs (TSX: LABS) reported their third quarter financial results. Reported...

Tuesday, November 17, 2020, 03:37:00 PM

BMO Expects K92 Mining To Miss 2021 Production Guidance

On October 18th, K92 Mining Inc. (TSX: KNT) reported their third quarter production results. The...

Thursday, October 21, 2021, 11:49:00 AM

K92: BMO Trims 2022 Production Estimates After Q2 Results

K92 Mining Inc. (TSX: KNT) reported its second quarter production results last week. The company...

Monday, July 18, 2022, 11:30:50 AM

Hecla Mining: Canaccord Reduces Price Target To $5.75 Following Earnings

Thursday, Hecla Mining (NYSE: HL) reported their fourth quarter and full year 2020 financial results....

Saturday, February 20, 2021, 02:34:00 PM